OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
54
Results
Show all
Save search
Copy query
Show results for
Unknown
(48)
Genomics
(3)
Transcriptomics
(2)
Proteomics
(1)
Organisms
Mus musculus
(1)
Homo sapiens
(1)
Alphavirus
(1)
Anemia
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Nostoc sp. PCC 7120 = FACHB-418
(1)
Oropouche virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Staphylococcus aureus
(1)
Tick-borne encephalitis virus
(1)
Organisms
Mus musculus
(1)
Homo sapiens
(1)
Repository
ENA
(3)
geo
(2)
pride
(1)
Tissue
Extracellular space
(1)
Tear
(1)
Disease
Graves ophthalmopathy
(1)
Technology Type
Data-dependent acquisition
(1)
Mass Spectrometry
(1)
First Public Date
2026
(2)
2024
(1)
Release Date
2022
(12)
2025
(6)
2023
(6)
2021
(6)
2020
(5)
2024
(4)
2019
(3)
2018
(2)
2017
(2)
2015
(2)
Lab affiliation
Byers Eye Institute, Stanford University
(1)
Publication date
2026
(2)
2024
(1)
Tags
xref:PubMed:42069852
(1)
xref:PubMed:39817456
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Teprotumumab-Related Hyperglycemia.
Not available
S-EPMC10211488
|
biostudies-literature
Cite
Teprotumumab: A Review in Thyroid Eye Disease.
Not available
S-EPMC9718703
|
biostudies-literature
Cite
Efficacy and Safety of Teprotumumab in Thyroid Eye Disease.
Not available
S-EPMC8630371
|
biostudies-literature
Cite
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Not available
S-EPMC5718164
|
biostudies-literature
Cite
Teprotumumab: a disease modifying treatment for graves' orbitopathy.
Not available
S-EPMC7334856
|
biostudies-literature
Cite
Improvement of asymmetric thyroid eye disease with teprotumumab.
Not available
S-EPMC9132868
|
biostudies-literature
Cite
Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report.
Not available
S-EPMC10074260
|
biostudies-literature
Cite
Patterns of Teprotumumab-Induced Hearing Dysfunction: A Systematic Review.
Not available
S-EPMC12379858
|
biostudies-literature
Cite
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease.
Not available
S-EPMC9308628
|
biostudies-literature
Cite
Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy.
Not available
S-EPMC7529924
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
